摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-dioctylpyridine | 47241-48-5

中文名称
——
中文别名
——
英文名称
2,6-dioctylpyridine
英文别名
——
2,6-dioctylpyridine化学式
CAS
47241-48-5
化学式
C21H37N
mdl
——
分子量
303.531
InChiKey
IARIVDQPXIQGSO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.6
  • 重原子数:
    22
  • 可旋转键数:
    14
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2,6-dioctylpyridine三氟甲烷磺酸甲酯二氯甲烷 为溶剂, 以53%的产率得到1-Methyl-2,6-dioctylpyridin-1-ium;trifluoromethanesulfonate
    参考文献:
    名称:
    Strategies To Reduce hERG K+Channel Blockade. Exploring Heteroaromaticity and Rigidity in Novel Pyridine Analogues of Dofetilide
    摘要:
    Drug-induced blockade of the human ether-a-go-go-related gene K+ channel (hERG) represents one of the major antitarget concerns in pharmaceutical industry. SAR studies of this ion channel have shed light on the structural requirements for hERG interaction but most importantly may reveal drug design principles to reduce hERG affinity. In the present study, a novel library of neutral and positively charged heteroaromatic derivatives of the class III antiarrhythmic agent dofetilide was synthesized and assessed for hERG affinity in radioligand binding and manual patch clamp assays. Structural modifications of the pyridine moiety, side chain, and peripheral aromatic moieties were evaluated, thereby revealing approaches for reducing hERG binding affinity. In particular, we found that the extra rigidity imposed close to the positively charged pyridine moiety can be very efficient in decreasing hERG affinity.
    DOI:
    10.1021/jm301564f
  • 作为产物:
    描述:
    1-辛炔copper(l) iodide 、 trans-bis(triphenylphosphine)palladium dichloride 、 palladium 10% on activated carbon 、 氢气三乙胺 作用下, 以 四氢呋喃甲醇 为溶剂, 20.0 ℃ 、250.0 kPa 条件下, 反应 0.5h, 生成 2,6-dioctylpyridine
    参考文献:
    名称:
    Strategies To Reduce hERG K+Channel Blockade. Exploring Heteroaromaticity and Rigidity in Novel Pyridine Analogues of Dofetilide
    摘要:
    Drug-induced blockade of the human ether-a-go-go-related gene K+ channel (hERG) represents one of the major antitarget concerns in pharmaceutical industry. SAR studies of this ion channel have shed light on the structural requirements for hERG interaction but most importantly may reveal drug design principles to reduce hERG affinity. In the present study, a novel library of neutral and positively charged heteroaromatic derivatives of the class III antiarrhythmic agent dofetilide was synthesized and assessed for hERG affinity in radioligand binding and manual patch clamp assays. Structural modifications of the pyridine moiety, side chain, and peripheral aromatic moieties were evaluated, thereby revealing approaches for reducing hERG binding affinity. In particular, we found that the extra rigidity imposed close to the positively charged pyridine moiety can be very efficient in decreasing hERG affinity.
    DOI:
    10.1021/jm301564f
点击查看最新优质反应信息

文献信息

  • DONOR-MODIFIED OLEFIN POLYMERIZATION CATALYSTS
    申请人:W.R. GRACE & CO.-CONN.
    公开号:EP1058696A1
    公开(公告)日:2000-12-13
  • Catalyst systems of the ziegler-natta type and a method for production thereof
    申请人:Fottinger Klaus
    公开号:US20050075241A1
    公开(公告)日:2005-04-07
    A method for production of catalytic systems of the Ziegler-Natta type is characterised in comprising the following steps: A) bringing an inorganic metal oxide and a magnesium compound of formula MgR n X 2-n into contact, where X=independently, fluorine, chlorine, bromine, iodine, hydrogen, NR 2 , OR, SR, SO 3 R or OC(O)R and R=independently, C 1 -C 20 linear, branched, or cyclic alkyl, a C 2 -C 10 alkenyl, an alkylaryl with 1-10 C atoms in the alkyl group and 6-20 C atoms in the aryl group, or a C 6 -C 18 aryl and n=1 or 2, then, B) bringing the intermediate product obtained in step A) into contact with a halogenating reagent, C) bringing the intermediate product obtained in step B) into contact with a) a tetravalent titanium compound, b) a metallo-organic compound of group 3 of the periodic system and c) optionally, an electron-donor compound and D) washing the product obtained in step C) with an aprotic solvent. The invention further relates to a catalytic system obtained as above and a method for the polymerisation of olefins.
  • US6228792B1
    申请人:——
    公开号:US6228792B1
    公开(公告)日:2001-05-08
  • [EN] DONOR-MODIFIED OLEFIN POLYMERIZATION CATALYSTS<br/>[FR] CATALYSEURS DE POLYMERISATION D'OLEFINES MODIFIES PAR DONNEUR
    申请人:W.R. GRACE & CO.-CONN.
    公开号:WO1999043722A1
    公开(公告)日:1999-09-02
    (EN) Supported Ziegler-Natta catalyst component adapted for the polymerization of ethylene is provided. More specifically, certain organomagnesium compounds (e.g., dibutylmagnesium) which do not contain an oxygen linkage between the organo moiety and the magnesium are impregnated into a porous inorganic oxide support (e.g., agglomerated silica particles) to form a first reaction product. The first reaction product is halogenated, e.g., with HCl, to convert the organomagnesium derived component to MgCl2 thereby forming a second reaction product. The second reaction product is then treated with a transition metal compound (e.g., TiCl4), a particular type of electron donor (e.g., 2,6-dimethyl pyridine) and optionally at least one Group 2 or 13 organo metal compound (e.g., diethylaluminum chloride). The combination of the particular organomagnesium compounds and electron donor impart a low melt flow ratio and enhanced activity to resulting catalyst component.(FR) L'invention concerne un constituant de catalyseurs Ziegler-Natta sur support adapté à la polymérisation d'éthylène. Plus spécifiquement, certains composés organomagnésiens (par exemple, le dibutylmagnésium) ne contenant pas de liaison oxygène entre la fraction organo et le magnésium sont imprégnés dans un support d'oxyde poreux inorganique (par exemple, des particules de silice agglomérées) afin de former un premier produit de réaction. Le premier produit de réaction est halogéné, par exemple, avec HCI, afin de convertir le composant dérivé d'organomagnésium en MgCl2, formant ainsi un second produit de réaction. Le second produit de réaction est ensuite traité avec un composé métallique de transition (par exemple, TiCl4), un type particulier d'un donneur d'électrons (par exemple, 2,6-diméthylpyridine) et facultativement au moins un composé organométallique des groupes 2 ou 13 (par exemple, le chlorure de diéthylaluminium). La combinaison des composés d'organomagnésium particuliers et du donneur d'électrons confère un rapport de fusion faible et une meilleure activité au constituant de catalyseur obtenu.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-